SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 29, Issue 34, 2011, Pages 4592-4593

DNMT3A mutations in acute myeloid leukemia: Impact on low-risk patients with CEBPA mutations

(1) Masuda, Shigeo a

a JICHI MEDICAL UNIVERSITY (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CD135 ANTIGEN; DNA METHYLTRANSFERASE 3A; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER PATIENT; CANCER RISK; CYTOGENETICS; GENE MUTATION; GENOTYPE; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

DNA (CYTOSINE-5-)-METHYLTRANSFERASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MUTATION; TUMOR MARKERS, BIOLOGICAL;

EID: 83355163398 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2011.38.2127 Document Type: Letter

Times cited : (7)

References (6)

1
- 79960735923
- Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia
- Thol F, Damm F, Lüdeking A, et al: Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol 29:2889-2896, 2011
- (2011) J Clin Oncol , vol.29 , pp. 2889-2896
- Thol, F.¹ Damm, F.² Lüdeking, A.³

2
- 77449146413
- Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome
- Dufour A, Schneider F, Metzeler KH, et al: Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. J Clin Oncol 28:570-577, 2010
- (2010) J Clin Oncol , vol.28 , pp. 570-577
- Dufour, A.¹ Schneider, F.² Metzeler, K.H.³

3
- 1442356729
- CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: Prognostic relevance and analysis of cooperating mutations
- DOI 10.1200/JCO.2004.06.060
- Fröhling S, Schlenk RF, Stolze I, et al: CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: Prognostic relevance and analysis of cooperating mutations. J Clin Oncol 22:624-633, 2004 (Pubitemid 41095065)
- (2004) Journal of Clinical Oncology , vol.22 , Issue.4 , pp. 624-633
- Frohling, S.¹ Schlenk, R.F.² Stolze, I.³ Bihlmayr, J.⁴ Benner, A.⁵ Kreitmeier, S.⁶ Tobis, K.⁷ Dohner, H.⁸ Dohner, K.⁹

4
- 59149096563
- Dysregulation of the C/EBPalpha differentiation pathway in human cancer
- Koschmieder S, Halmos B, Levantini E, et al: Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol 27:619-628, 2009
- (2009) J Clin Oncol , vol.27 , pp. 619-628
- Koschmieder, S.¹ Halmos, B.² Levantini, E.³

5
- 79952122978
- Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: Further evidence for CEBPA double mutant AML as a distinctive disease entity
- Taskesen E, Bullinger L, Corbacioglu A, et al: Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: Further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood 117:2469-2475, 2011
- (2011) Blood , vol.117 , pp. 2469-2475
- Taskesen, E.¹ Bullinger, L.² Corbacioglu, A.³

6
- 63849241865
- Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
- Wouters BJ, Löwenberg B, Erpelinck-Verschueren CA, et al: Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood 113:3088-3091, 2009
- (2009) Blood , vol.113 , pp. 3088-3091
- Wouters, B.J.¹ Löwenberg, B.² Erpelinck-Verschueren, C.A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.